“…Very recently, Zhang et al developed a non-invasive prenatal sequencing test based on the unique molecular indexing method to diagnose dominant monogenic disorders. This test ( Stevenson et al, 1978) U S N A 2 8 3 ( Hall et al, 1992) U S 4 3 3 3 4 ( Hall et al, 1992) U S 1 30 28 5 ( Hall et al, 1992) U S 1 NA 21 6 ( Hall et al, 1992) U S 1 32 22 7 ( Andrews et al, 1993) Brazil NA 23 8 ( Bratanic et al, 1994) Slovenia 43 39 9 ( Ito et al, 1996) Japan NA 25 10 (Przylepa et al, 1996) U S 1 NA NA 11 (Krepelová et al, 1998) Czech 24 24 12 (Wang et al, 2002) Taiwan 34 31 13 (Akai et al, 2002) Japan NA NA 14 (Izakovic et al, 2003) U S N A 3 4 15 (Vargas et al, 2003) Chile 36 28 16 (Vargas et al, 2003) Brazil 30 32 17 (Upmeyer et al, 2005) U S N A N A 18 (Erol and Eser, 2006) Turkey NA NA 19 (McGaughran et al, 2006) Australia 62 28 20 (Eun et al, 2007) Korea 50 32 21 (Fonseca et al, 2008) Brazil 30 23 22 (Slavotinek et al, 2009) U S 4 8 4 0 23 (Tao et al, 2010) successfully identified cases of FGFR2-related craniosynostosis, including Apert (FGFR2: c.758C > G), Pfeiffer (FGFR2: c.870G > T), and Crouzon (FGFR2: c.1032G > A) syndromes, and it accurately distinguished those cases from other FGFR3-related skeletal disorders (e.g. thanatophoric dysplasia and achondroplasia) (Zhang et al, 2019).…”